Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Cancer Research|April 15, 1997
A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID miceN Sato, M E Gleave, N Bruchovsky, et al.
Cancer|November 1, 1982
A critical evaluation of a specific radioimmunoassay for prostatic acid phosphataseS L Goldenberg, H K Silver, L D Sullivan, et al.
British Journal of Urology|June 20, 1998
An evaluation of quality of life in patients with continent urinary diversions after cystectomyL D Sullivan, V D Chow, D S Ko, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 1, 1996
[Hormone release and intermittent hormonal therapy in the LN CaP model of human prostate cancer]M Gleave, N Santo, P S Rennie, et al.
Cancer|May 1, 1993
Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigenK Akakura, N Bruchovsky, S L Goldenberg, et al.
The Journal of Urology|August 1, 1995
The correlation of multichannel urodynamic pressure-flow studies and American Urological Association symptom index in the evaluation of benign prostatic hyperplasiaD S Ko, H N Fenster, K Chambers, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 13, 2021
Simulated effects of early menopausal bone mineral density preservation on long-term fracture risk: a feasibility studyE O Billington, W D Leslie, J P Brown, et al.
British Journal of Urology|March 6, 1998
Retroperitoneal lymphadenectomy for post-chemotherapy residual masses: is a modified dissection and resection of residual masses sufficient?F Rabbani, S L Goldenberg, M E Gleave, et al.
Seminars in Urologic Oncology|May 1, 1996
Optimal duration of neoadjuvant androgen withdrawal therapy before radical prostatectomy in clinically confined prostate cancerM E Gleave, S L Goldenberg, E C Jones, et al.
Urology|May 1, 1996
Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancerM E Gleave, D Coupland, D Drachenberg, et al.
Pageof 12